Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Safety and Outcomes in Infants Born to Mothers Participating in Retosiban Treatment Trials: ARIOS Follow-up Study.
Journal: American journal of perinatology
Published: August 05, 2021
Development of standard definitions and grading for Maternal and Fetal Adverse Event Terminology.
Journal: Prenatal diagnosis
Published: July 24, 2021
Erratum: Randomized Trials of Retosiban versus Placebo or Atosiban in Spontaneous Preterm Labor.
Journal: American journal of perinatology
Published: July 08, 2021
Randomized Trials of Retosiban Versus Placebo or Atosiban in Spontaneous Preterm Labor.
Journal: American journal of perinatology
Published: May 08, 2020
A Retrospective Database Analysis of Neonatal Morbidities to Evaluate a Composite Endpoint for Use in Preterm Labor Clinical Trials.
Journal: AJP reports
Published: May 02, 2017
Assessing a composite end point for new tocolytics in clinical trials: Data from 4 US integrated delivery networks.
Journal: Pharmacoepidemiology and drug safety
Published: April 01, 2017
A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.
Journal: Clinical pharmacology in drug development
Published: October 11, 2016
Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study.
Journal: British journal of clinical pharmacology
Published: October 21, 2014
Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.
Journal: BMC medical research methodology
Published: August 05, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026